Dr. Gregory Biedermann, MD
Claim this profileUniversity of Missouri - Ellis Fischel
Studies Cancer
Studies Brain Tumor
9 reported clinical trials
32 drugs studied
Area of expertise
1Cancer
Stage IV
Stage I
Stage II
2Brain Tumor
IDH positive
1p/19q co-deletion positive
Stage IV
Affiliated Hospitals
Clinical Trials Gregory Biedermann, MD is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria
More about Gregory Biedermann, MD
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Gregory Biedermann, MD has experience with
- Radiation Therapy
- Histrelin
- Bicalutamide
- Leuprolide
- Triptorelin
- Goserelin
Breakdown of trials Gregory Biedermann, MD has run
Cancer
Brain Tumor
Breast Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Biedermann, MD specialize in?
Gregory Biedermann, MD focuses on Cancer and Brain Tumor. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Gregory Biedermann, MD currently recruiting for clinical trials?
Yes, Gregory Biedermann, MD is currently recruiting for 6 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Gregory Biedermann, MD has studied deeply?
Yes, Gregory Biedermann, MD has studied treatments such as Radiation Therapy, Histrelin, Bicalutamide.
What is the best way to schedule an appointment with Gregory Biedermann, MD?
Apply for one of the trials that Gregory Biedermann, MD is conducting.
What is the office address of Gregory Biedermann, MD?
The office of Gregory Biedermann, MD is located at: University of Missouri - Ellis Fischel, Columbia, Missouri 65212 United States. This is the address for their practice at the University of Missouri - Ellis Fischel.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.